Table of Contents Author Guidelines Submit a Manuscript
Malaria Research and Treatment
Volume 2012, Article ID 381724, 5 pages
http://dx.doi.org/10.1155/2012/381724
Research Article

Efficacy of Eosin B as a New Antimalarial Drug in a Murine Model

1Department of Biochemistry, Pasteur Institute of Iran, Tehran 1316943551, Iran
2Department of Biochemistry, Payame Noor University, Tahran 193195, Iran
3Department of Parasitology, Pasteur Institute of Iran, Tehran 1316943551, Iran
4Department of Clinical Research, Pasteur Institute of Iran, Tehran 1316943551, Iran

Received 21 May 2012; Revised 28 August 2012; Accepted 27 November 2012

Academic Editor: Donatella Taramelli

Copyright © 2012 Zahra Zamani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World malaria Report, 2011, http://www.who.int/malaria/world_malaria_report_2011/WMR2011_factsheet.pdf.
  2. N. J. White and P. L. Olliaro, “Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria,” Parasitology Today, vol. 12, no. 10, pp. 399–401, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Dondorp, F. Nosten, P. Yi et al., “Artemisinin resistance in Plasmodium falciparum malaria,” New England Journal of Medicine, vol. 361, no. 5, pp. 455–467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Guttmann and P. Ehrlich, “Ueber die Wirkung des Methylenblau bei Malaria,” Berliner Klinische Wochenschrift, 1891.
  5. J. L. Vennerstrom, M. T. Makler, C. K. Angerhofer, and J. A. Williams, “Antimalarial dyes revisited: xanthenes, azines, oxazines and thiazines,” Antimicrobial Agents and Chemotherapy, vol. 39, no. 12, pp. 2671–2677, 1995. View at Google Scholar · View at Scopus
  6. G. Mandi, S. Witte, P. Meissner et al., “Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso,” Tropical Medicine and International Health, vol. 10, no. 1, pp. 32–38, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. P. E. Meissner, G. Mandi, S. Witte et al., “Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso,” Malaria Journal, vol. 4, article 45, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. P. E. Meissner, G. Mandi, B. Coulibaly et al., “Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine,” Malaria Journal, vol. 5, article 84, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Coulibaly, A. Zoungrana, F. P. Mockenhaupt et al., “Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial,” PLoS ONE, vol. 4, no. 5, article e5318, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. C. E. Atreya, E. F. Johnson, J. J. Irwin et al., “A molecular docking strategy identifies eosin B as a non-active site inhibitor of protozoal bifunctional thymidylate synthase-dihydrofolate reductase,” Journal of Biological Chemistry, vol. 278, no. 16, pp. 14092–14100, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. Federal Register, D&C Red no. 21 and D&C Red no. 22. Federal Register vol. 47, pp. 53843–53846, 1982.
  12. F. Sperling, “Nonlethal parameters as indices of acute toxicity: inadequacy of the acute LD50,” in New Concepts of Safety Evaluation, D. A. Dayan, Ed., p. 177, John Wiley and Sons, New York, NY, USA, 1976. View at Google Scholar
  13. J. Trevan, “The error of determination of toxicity,” Proceedings of the Royal Society B, vol. 101, pp. 483–514, 1927. View at Google Scholar
  14. W. Peters, “Drug resistance in Plasmodium berghei. Chloroquine resistance,” Experimental Parasitology, vol. 17, no. 1, pp. 80–89, 1965. View at Google Scholar · View at Scopus
  15. K. Arora and A. K. Srivastava, “Antimalarial efficacy of methylene blue and menadione and their effect on glutathione metabolism of Plasmodium yoelii-infected albino mice,” Parasitology Research, vol. 97, no. 6, pp. 521–526, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. K. M. Massimine, M. T. McIntosh, L. T. Doan et al., “Eosin B as a novel antimalarial agent for drug-resistant Plasmodium falciparum,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 9, pp. 3132–3141, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Zimmerman and K. Fritz Wolf, WIPO Patent Application WO/2006/097472 BECKER-BRANDENBURG, 2006, http://www.sumobrain.com/patents/wipo/Novel-inhibitors-glutathione-s-transferase/WO2006097472.html.